{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:41:22Z","timestamp":1780497682155,"version":"3.54.1"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.urology.2023.11.024","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T04:02:56Z","timestamp":1701835376000},"page":"122-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Changes in Point of Maximal Curvature During Collagenase Clostridium Histolyticum Injections for Peyronie\u2019s Disease"],"prefix":"10.1016","volume":"184","author":[{"given":"Henry","family":"Larson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Kohler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Ziegelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6842-733X","authenticated-orcid":false,"given":"Landon","family":"Trost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2023.11.024_bib1","article-title":"Treatment patterns and healthcare outcomes with collagenase Clostridium histolyticum vs surgery in Peyronie's disease: a retrospective claims database analysis","volume":"9","author":"Trost","year":"2021","journal-title":"Sex Med"},{"key":"10.1016\/j.urology.2023.11.024_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.urology.2018.06.003","article-title":"Plaque calcification: an important predictor of collagenase Clostridium histolyticum treatment outcomes for men with Peyronie's disease","volume":"119","author":"Wymer","year":"2018","journal-title":"Urology"},{"key":"10.1016\/j.urology.2023.11.024_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.euf.2022.09.019","article-title":"Collagenase Clostridium histolyticum treatment improves degree of curvature in Peyronie's disease with calcified plaques","volume":"9","author":"Masterson","year":"2023","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urology.2023.11.024_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.urology.2019.01.055","article-title":"Safety and efficacy of collagenase Clostridium histolyticum in Peyronie's disease men with ventral curvatures","volume":"129","author":"Alom","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.urology.2023.11.024_bib5","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/jsxmed\/qdac006","article-title":"Efficacy of collagenase Clostridium histolyticum in men with congenital penile curvature","volume":"20","author":"Kulkarni","year":"2023","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2023.11.024_bib6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.urology.2020.07.048","article-title":"Safety and efficacy of collagenase Clostridium histolyticum in the treatment of acute phase Peyronie's disease: a multi-institutional analysis","volume":"145","author":"Nguyen","year":"2020","journal-title":"Urology"},{"key":"10.1016\/j.urology.2023.11.024_bib7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","article-title":"Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies","volume":"190","author":"Gelbard","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2023.11.024_bib8","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jsxm.2019.03.007","article-title":"Efficacy of combined collagenase Clostridium histolyticum and RestoreX penile traction therapy in men with Peyronie's sisease","volume":"16","author":"Alom","year":"2019","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2023.11.024_bib9","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.jsxm.2018.08.012","article-title":"Sildenafil 25 mg ODT + collagenase Clostridium hystoliticum vs collagenase Clostridium hystoliticum alone for the management of Peyronie's sisease: a matched-pair comparison analysis","volume":"15","author":"Cocci","year":"2018","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2023.11.024_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.urology.2022.09.017","article-title":"Improved Peyronie's disease curvature outcomes using a novel collagenase administration protocol","author":"Flores","year":"2022","journal-title":"Urology"},{"key":"10.1016\/j.urology.2023.11.024_bib11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.urology.2017.04.045","article-title":"Self-reported clinical meaningfulness early in the treatment course predicts objective outcomes in men undergoing collagenase Clostridium histolyticum injections for Peyronie disease","volume":"106","author":"Ziegelmann","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.urology.2023.11.024_bib12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/jsxmed\/qdac030","article-title":"Multiple courses of intralesional collagenase injections for Peyronie disease: a retrospective analysis","volume":"20","author":"Li","year":"2023","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2023.11.024_bib13","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.juro.2015.10.065","article-title":"Restoration of penile function and patient satisfaction with intralesional collagenase Clostridium histolyticum injection for Peyronie's disease","volume":"195","author":"Ziegelmann","year":"2016","journal-title":"J Urol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042952301018X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042952301018X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T14:38:33Z","timestamp":1709649513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009042952301018X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":13,"alternative-id":["S009042952301018X"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2023.11.024","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in Point of Maximal Curvature During Collagenase Clostridium Histolyticum Injections for Peyronie\u2019s Disease","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2023.11.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}